WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 1 fonti

Clinical trial indicates triple dose of Ozempic is more effective - UPI.com

A triple-sized weekly dose of Ozempic works better to help people with obesity shed excess pounds without significant side effects, a clinical trial found.

Raccontata daupi.com

Timeline cronologica

  1. lunedì 15 settembre 2025·upi.com

    Research finds half of Ozempic patients quit within a year - UPI.com

    Half of people who start taking the GLP-1 weight-loss drugs Ozempic and Wegovy drop it within a year, Danish researchers reported at a conference in Vienna.

  2. martedì 16 settembre 2025·upi.com

    Clinical trial indicates triple dose of Ozempic is more effective - UPI.com

    A triple-sized weekly dose of Ozempic works better to help people with obesity shed excess pounds without significant side effects, a clinical trial found.